Literature DB >> 6796310

Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C).

J J van de Kamp, M F Niermeijer, K von Figura, M A Giesberts.   

Abstract

A study of 73 patients with the Sanfilippo syndrome (36 patients with Sanfilippo A disease, 23 with Sanfilippo B disease and 14 with Sanfilippo C disease) revealed both intertype and intratype variability. The course of the disease was relatively mild in Sanfilippo B disease and dementia was less severe. Type A showed earlier onset with more severe clinical manifestations and an earlier age at death. Sanfilippo C disease was slightly less severe than Sanfilippo A disease. The intratype variability may be explained in part by differences in genetic and environmental background. In Sanfilippo B disease, genetic heterogeneity is suggested by the observation of a more severe and a mild variant, and this variation may be due to the involvement of different allelic mutations. The intrafamilial variability of the different types was small, but in three families with Sanfilippo B disease intrafamilial variability was evident.

Entities:  

Mesh:

Year:  1981        PMID: 6796310     DOI: 10.1111/j.1399-0004.1981.tb01821.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  55 in total

1.  Molecular defects in Sanfilippo syndrome type B (mucopolysaccharidosis IIIB).

Authors:  C E Beesley; M Jackson; E P Young; A Vellodi; B G Winchester
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  The molecular basis of Sanfilippo syndrome type B.

Authors:  H G Zhao; H H Li; G Bach; A Schmidtchen; E F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Sanfilippo syndrome type D in two adolescent sisters.

Authors:  L Siciliano; A Fiumara; L Pavone; C Freeman; D Robertson; C P Morris; J J Hopwood; P Di Natale; S Musumeci; A L Horwitz
Journal:  J Med Genet       Date:  1991-06       Impact factor: 6.318

4.  Growth in patients with mucopolysaccharidosis type III (Sanfilippo disease).

Authors:  J de Ruijter; L Broere; M F Mulder; A T van der Ploeg; M E Rubio-Gozalbo; S B Wortmann; G Visser; F A Wijburg
Journal:  J Inherit Metab Dis       Date:  2013-10-31       Impact factor: 4.982

Review 5.  Behavioural phenotypes of the mucopolysaccharide disorders: a systematic literature review of cognitive, motor, social, linguistic and behavioural presentation in the MPS disorders.

Authors:  E M Cross; D J Hare
Journal:  J Inherit Metab Dis       Date:  2013-02-06       Impact factor: 4.982

6.  Identification of a common mutation (R245H) in Sanfilippo A patients from The Netherlands.

Authors:  B Weber; J J van de Kamp; W J Kleijer; X H Guo; L Blanch; O P van Diggelen; R Wevers; B J Poorthuis; J J Hopwood
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

7.  Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype.

Authors:  Marlies J Valstar; Hennie T Bruggenwirth; Renske Olmer; Ron A Wevers; Frans W Verheijen; Ben J Poorthuis; Dicky J Halley; Frits A Wijburg
Journal:  J Inherit Metab Dis       Date:  2010-09-18       Impact factor: 4.982

8.  Mass spectrometry-based protein profiling to determine the cause of lysosomal storage diseases of unknown etiology.

Authors:  David E Sleat; Lin Ding; Shudan Wang; Caifeng Zhao; Yanhong Wang; Winnie Xin; Haiyan Zheng; Dirk F Moore; Katherine B Sims; Peter Lobel
Journal:  Mol Cell Proteomics       Date:  2009-04-20       Impact factor: 5.911

9.  Identification of 12 novel mutations in the alpha-N-acetylglucosaminidase gene in 14 patients with Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB).

Authors:  C E Beesley; E P Young; A Vellodi; B G Winchester
Journal:  J Med Genet       Date:  1998-11       Impact factor: 6.318

10.  Clinical heterogeneity in Sanfilippo disease (mucopolysaccharidosis III) type D: presentation of two new cases.

Authors:  G V Coppa; P L Giorgi; L Felici; O Gabrielli; E Donti; S Bernasconi; H Kresse; E Paschke; C Mastropaolo
Journal:  Eur J Pediatr       Date:  1983-04       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.